These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26673619)

  • 1. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
    Liu BL; Sun KX; Zong ZH; Chen S; Zhao Y
    Oncotarget; 2016 Feb; 7(6):6649-64. PubMed ID: 26673619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
    Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
    Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
    Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
    Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.
    Wang Q; Tang H; Yin S; Dong C
    Oncol Rep; 2013 May; 29(5):2046-52. PubMed ID: 23446431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
    Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
    Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma.
    Wu X; Cai D; Zhang F; Li M; Wan Q
    Life Sci; 2019 Aug; 231():116549. PubMed ID: 31200002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
    Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
    He Z; Xu H; Meng Y; Kuang Y
    Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
    Li L; Qu YW; Li YP
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
    Zheng WP; Meng FL; Wang LY
    Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
    Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
    PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
    Ruan H; Liang X; Zhao W; Ma L; Zhao Y
    Biomed Pharmacother; 2017 May; 89():812-818. PubMed ID: 28273643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
    Li Q; Shen F; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.